Navigation Links
Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation
Date:7/22/2014

WASHINGTON, July 22, 2014 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced that Edwards' Chairman and CEO Michael A. Mussallem today served as an expert panelist at the invitation of the United States Energy and Commerce Committee's Subcommittee on Health to discuss medical device innovation at its hearing, "21st Century Cures: Examining Barriers to Ongoing Evidence Development and Communication."

"Edwards has five decades of experience in developing and delivering new therapies to American patients, and we are concerned about the alarming and documented decline in U.S. medical innovation," said Mussallem.  "We identified areas of improvement that we believe can support a balanced ecosystem, which welcomes innovations to enable patients to live longer, healthier lives."

Mussallem noted the constructive and collaborative relationship with the Food and Drug Administration and the Centers for Medicare & Medicaid Services and identified three primary areas of improvement to promote America's leadership in medical device development, and ensure delivery of new treatments to patients around the world:

  • Evidence development mechanisms can be improved to reduce costs and delays.
  • Economic incentives need to be aligned with promoting innovation.
  • FDA's vision to improve the regulatory process must be accelerated.  

Mussallem drew on Edwards' experience with the SAPIEN transcatheter aortic heart valves to discuss the regulatory and reimbursement challenges and opportunities in the U.S.  His full written comments can be read at http://energycommerce.house.gov/hearing/barriers-ongoing-communication-and-evidence-development.  To learn more about the hearing or view a webcast of the event, visit the Energy and Commerce Committee's website at http://energycommerce.house.gov/studio/webcasts.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring.  Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring, enabling them to save and enhance lives. Additional company information can be found at www.edwards.com

Edwards, Edwards Lifesciences, the stylized E logo and SAPIEN are trademarks of Edwards Lifesciences Corporation.  All other trademarks are the property of their respective owners.

Logo - http://photos.prnewswire.com/prnh/20140714/126903


'/>"/>
SOURCE Edwards Lifesciences Corporation
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
2. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
3. Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344
4. Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")
5. Edwards Lifesciences Chief Medical Officer to Keynote the Inaugural MedTech Cardio 2012 Conference at the MD&M Minneapolis Exposition and Conference
6. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
7. Acquisitions, Conference Participations, Court Rulings, and Product Deliveries - Research Report on Zoetis, Aegerion Pharmaceuticals, Edwards, Community Health Systems, and Air Methods
8. New Appointments, and Share Price Movements - Research Report on Humana, Illumina, Edwards Lifesciences, Aegerion Pharmaceuticals, and CytRx
9. RxAlly Member Pharmacies Invited To Become The Preferred Network For Smart Insurance Company Holdings, Inc.
10. NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London
11. PuraMed BioScience Invited to Discuss LipiGesic M on Armed Forces Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
(Date:6/23/2016)... Pa. , June 23, 2016 The ... in an outpatient dialysis facility.  Treatments are usually 3 ... 6 hours per visit, including travel time, equipment preparation ... a patient, but especially grueling for patients who are ... of a skilled nursing and rehabilitation centers for some ...
Breaking Medicine Technology:
(Date:6/23/2016)... Angeles, CA (PRWEB) , ... June 23, 2016 , ... ... conducted that may expose a possible link between head and neck cancer in individuals ... participating in the study were evaluated based on whether they had gum disease, brushed ...
(Date:6/23/2016)... Beaumont, TX (PRWEB) , ... June 23, 2016 , ... ... family and business clients throughout Jasper County and the surrounding region, is initiating a ... The charity drive will raise funds earmarked for a scholarship fund that will be ...
(Date:6/23/2016)... ... June 23, 2016 , ... Virginia Beach resident Sean Kelly suffered from depression ... water to find peace and set out to accomplish a personal mission: a solo ... the internet. He came across the story of another special operations veteran, Josh Collins, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the 20th International Congress of Parkinson’s Disease and Movement Disorders. This special session ... experts, highlighting the relevance, novelty, and quality of both clinical and basic research ...
(Date:6/23/2016)... ... ... The U.S. Supreme Court decision on immigration has significant consequences for Social Security ... (TSCL) . “President Obama’s executive actions on immigration would have provided long - ... country illegally, even though the newly - issued green cards are only temporary,” says ...
Breaking Medicine News(10 mins):